Largest Shareholder Deokyoung Kang's Stake Slightly Drops from 42.17% to 41.90% Due to Related Party's Market Sale, No Impact on Management Control


  • Largest shareholder group's stake decreased by 0.27%p (42,465 shares) from 42.17% to 41.90%.
  • Reason: Special related person Kim Seong-hwan sold all 42,465 shares in open market at KRW 19,289 per share.
  • Reporter has no specific plans regarding management influence; will act in line with company goals if needed.
  • Existing stock options for 3 executives (50,000 shares, 0.31%) remain unchanged.
  • Impact: Limited short-term price effect; negligible control dilution.
  • [AI Summary]The sale is interpreted as portfolio adjustment by a related party, with limited impact on stock price outlook. Low investment risk; no management control change expected; monitor for further moves.

KOSPI Filing Information


  • Filing: Report on Large Shareholding (General)
  • Company: KOREA UNITED PHARM (033270)
  • Submission: Deokyoung Kang
  • Receipt: 06-02-2026